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Neutrophils are unusual in their reliance on glycolysis to maintain
their energy requirements1 despite the presence of mitochondria
and tricarboxylic acid (TCA) cycle intermediaries.2 This metabolic
adaptation is thought in part to underpin their survival and anti-
microbial function in tissues that are typically hypoxic.3-5Despite their
uniquemetabolism, little is knownabout the importanceoffluxbetween
metabolic pathways in determining neutrophil survival responses.
Recent work has demonstrated the importance of the hypoxia-inducible
factor (HIF)/prolyl hydroxylase domain (PHD)–containing en-
zyme oxygen-sensing pathway in this regard, identifying bothHIF-1a
and PHD3 as critical regulators of neutrophil survival in hypoxia,6,7
with the extended survival of neutrophils in hypoxia being de-
pendent on HIF-1a expression. In parallel, an expanding body of
work has addressed the role of HIF-1a in coordinating macrophage
functional responses to proinflammatory mediators.8-11 This work
led to the observation that, in macrophages, lipopolysaccharide (LPS)
causes an intracellular increase in succinate levels, resulting in HIF-1a
stabilization and enhanced interleukin-1b signaling.11 Subsequently,
the metabolic rewiring of antimicrobial (M1) and tissue repair (M2)
macrophages has been elucidated, with important consequences of
TCA cycle activity and integrity for regulation of nitric oxide and
N-glycosylation signaling, respectively.12Whether TCA cycle activity
and succinate accumulation regulates HIF-1a and hypoxic survival in
neutrophils is unknown.
Patients with rare germ line mutations in genes encoding the
TCA cycle enzyme succinate dehydrogenase (SDH) allow us to
directly question the role of the TCA cycle and mitochondrial
respiratory chain in neutrophil survival responses. SDH oxidizes
succinate to fumarate in the TCA cycle and is a ubiquinone
oxidoreductase, also functioning in complex II of the respiratory
chain.13 SDH comprises four subunits (A-D), with inherited
mutations of each of the subunits linked to the development of
pheochromocytoma (PHEO) and paraganglioma (PGL) after somatic
inactivation of the wild-type allele and loss of heterozygosity.14-16
We questioned whether heterozygous germ line mutations in
SDHB (SDHBx) would reduce SDH activity in the peripheral blood
neutrophils of these patients, leading to accumulation of intracellu-
lar succinate, HIF-1a stabilization, and a pseudohypoxic sur-
vival phenotype, given the importance of the B subunit for SDH
catalytic function and its high prevalence within PHEO/PGL
patient populations.13,17,18
To determine whether succinate is implicated in regulating
neutrophil survival responses, we isolated peripheral blood
neutrophils from patients with heterozygous germ line SDHBx
mutations in whom an increase in intracellular succinate would
be predicted. In total, 20 individuals with frameshift, splice, missense,
or nonsense mutations were studied (supplemental Table 1, available
on the Blood Web site). Although all but 1 patient displayed plasma
succinate levels within the normal range, a significantly higher plasma
succinate level was observed in patients with SDHBx (Figure 1A). To
confirm the consequence ofSDHBmutations on intracellular succinate
and to measure other TCA cycle and glycolytic intermediaries,
peripheral blood neutrophils were isolated from 3 individuals with
SDHBx and 3 healthy controls, and relative metabolite abundance
wasdeterminedbygas chromatography–mass spectrometry (Figure 1B).
Succinate was significantly more abundant in neutrophils isolated from
patients with SDHBx than from controls. This finding was paralleled by
increases in lactic acid and citric acid, but no changes in other TCA cycle
intermediaries (a-ketoglutaric acid, fumaric acid, or malic acid) were
observed. Thus, neutrophils heterozygous for mutant SDHB gene
expression display the predicted elevation in intracellular succinate, but
with no decrease in downstream TCA cycle intermediaries. Citric acid
levels were increased, which may reflect an increase in biosynthetic
requirements outside the TCA cycle. In keeping with the increased
succinate in SDHBx neutrophils, a detectable increase in protein
succinylation was also observed (Figure 1C).
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The consequence of SDHB heterozygosity for constitutive rates
of neutrophil apoptosis and hypoxic survival responses was
determined. SDHBx neutrophils displayed both reduced constitutive
apoptosis and enhanced survival in hypoxia, as assessed both
by cellular morphology (Figure 1D) and Annexin-V positivity
(Figure 1E). Given the previous report of succinate-mediated
HIF-1a stabilization in bone marrow–derived macrophages,11 and
the importance of HIF-1a for hypoxic neutrophil survival,6 we
asked whether the reduced apoptosis in SDHBx neutrophils was
secondary to increased HIF-1a activity. HIF-1a protein in SDHBx
neutrophils was elevated in hypoxia (Figure 2A-B) but undetectable
in normoxic cells, in which reduced rates of apoptosis were
observed. Thus, the phenotype of enhanced neutrophil survival
in the setting of SDHB heterozygosity occurs independently of
HIF-1a protein expression. In keeping with unaltered HIF-1a
activity in normoxic SDHBx neutrophils, we saw no alterations either
in glucose uptake (Figure 2C-D), inwhich a hypoxic uplift is observed
in healthy control cells, or in extracellular acidification rates, an
indirect measure of glycolytic activity (Figure 2E). Interestingly, we
observed that neutrophils isolated from individuals with SDHB
mutations displayed significantly reduced levels of oxidant stress
(Figure 2F), a phenotype associated with enhanced neutrophil
survival in chronic granulomatous disease patients.19 However,
no differences in nicotinamide adenine dinucleotide phosphate
(NADP)/reduced NADP (NADPH) redox ratios were detected be-
tween patients and controls, suggesting the SDHB phenotype to be
independent of altered NADPH oxidase 2 activity (Figure 2G).
This finding led us to question whether SDH was regulating
apoptosis through its role as a mitochondrial ubiquinone oxidore-
ductase. SDHBx neutrophils demonstrated an increased ratio of
oxidized to reduced nicotinamide adenine dinucleotide (NAD)
(Figure 2H), and treatment of healthy human neutrophils with
the irreversible SDH inhibitor 3-nitropropionic acid reduced con-
stitutive neutrophil apoptosis (Figure 2I), thus implicating impaired
mitochondrial complex II and compensatory changes in the electron
transport chain in the enhanced survival of SDHB-mutant neutrophils.
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Figure 1. Heterozygous SDHB neutrophils display
a specific metabolic signature and enhanced sur-
vival. (A) Plasma succinate concentrations were de-
termined for 97 healthy controls (HC) and 19 patients
with germ line mutations in SDHB. Filled, half-filled, and
open circles represent patients without, with previous,
and with current tumors, respectively. Solid lines
represent median values, and dashed lines represent
upper and lower limits of reference. (B-E) Human
peripheral blood neutrophils from healthy controls (HC)
and SDHBx patients were studied in parallel. (B)
Relative metabolite abundance. Freshly isolated neu-
trophils were lysed in methanol, the liquid phase was
subjected to gas chromatography–mass spectrometry,
and relative quantification of 20 key metabolic intermedi-
aries was performed. Data represent mean6SEM, n5 3.
(C) Succinylation. Freshly isolated neutrophil lysates
were separated by SDS-PAGE, and membranes were
probed for succinylated protein expression relative to
b-actin control; blot is representative of n 5 3. (D-E)
Apoptosis. Neutrophils were cultured for 20 hours in
normoxia or hypoxia, and apoptosis was determined
by morphology (D) and flow cytometry (Annexin V) (E).
Solid bars represent mean; P values were determined
by Mann-Whitney U test (A), unpaired Student t test
(B), or 2-way ANOVA (D-E). ANOVA, analysis of variance;
PAGE, polyacrylamide gel electrophoresis; SDS, sodium
dodecyl sulfate; SEM, standard error of the mean.
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These studies use a valuable patient group with a specific
mutation in SDHB as an experimental system in which to delineate
the role of the TCA cycle and mitochondrial respiratory chain in
neutrophil survival responses. It provides the first description of
elevated intracellular succinate levels in neutrophils isolated from
patients with heterozygous mutations in SDHB and the first evidence
of a dysfunctional TCA cycle in resting-state peripheral blood
neutrophils. In marked contrast to the role of succinate in facilitating
HIF-1adependent inflammatory responses in LPS-stimulated macro-
phages, we dissociate enhanced neutrophil survival from HIF-1a
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Figure 2. SDHBx neutrophil survival is independent
of HIF-1a expression and linked to uncoupling of
the mitochondrial electron transport chain. Human
peripheral blood neutrophils from healthy controls (HC)
and SDHB patients were studied in parallel. (A-B) HIF-1a
protein expression. Freshly isolated neutrophils and
neutrophils aged for 4 hours in normoxia (N4) or
hypoxia (H4) were lysed and separated by SDS-PAGE,
the membranes were probed for HIF-1a and p38 MAPK
expression, and densitometry on hypoxic samples
was performed. Representative blot shown (A), with
mean densitometry 6 SEM, n 5 6 (B). (C-D) Glucose
uptake in healthy controls (C) and SDHB patients (D).
Neutrophils were preincubated in glucose-free phosphate-
buffered saline in normoxia (N) or hypoxia (H) for 1 hour
before stimulation with 100 nM N-formyl-methionyl-leucyl-
phenylalanine (fMLP) in the presence of 200 mM 2-(N-[7-
nitrobenz-2-oxa-1,3-diazol-4-yl]amino)-2-deoxyglucose
(2-NBDG) for 20 minutes. Uptake was determined
by flow cytometry (FL1 geometric mean fluorescence).
Data represent mean 6 SEM, n 5 5. (E) Glycolytic
capacity in healthy controls (filled) and SDHB patients
(open). Neutrophils were cultured with or without glucose,
2-deoxy-D-glucose (2DG; 10 mM), or LPS (1 mg/mL)
for 2 hours before stimulation with 100 nM fMLP, and
peak extracellular acidification rates were determined
by Seahorse. Data represent mean 6 SEM, n 5 4. (F)
Intracellular reactive oxygen species. 29,79-Dichlorofluor-
escein fluorescence was quantified after 45-minute
neutrophil culture in the presence or absence of fMLP
(100 nM), and fold change in patient neutrophil fluores-
cence was calculated relative to healthy controls. (G-H)
Electron transport. Ratios of oxidized to reduced NADP
(G) and NAD (H) were measured by fluorometric enzyme
cycling assay in freshly isolated and aged neutrophils
(6 hours). (I) Apoptosis. Neutrophils were cultured for 20
hours in the presence or absence of 3-nitropropionic
acid (3-NP; 0-2 mM), and apoptosis was determined by
morphological appearance; data represent mean 6 SEM,
n 5 4. P values were determined by unpaired (B), paired
(C, D, and I), or 1-sample (F) Student t tests, or by 2-way
ANOVA (G-H). ECAR, extracellular acidification rate;
OD, optical density.
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stabilization in the context of germ line mutations in SDH, linking it
instead to a phenotype of impaired mitochondrial complex II function
and reduced oxidative stress. Taken together, this work identifies
key metabolic differences between neutrophils and macrophages and
raises further important questions as to the metabolic control of neutro-
phil function and survival. Future work dissecting the consequences of
SDHBmutations for neutrophil host-pathogen responses and inflamma-
tion resolution will be key in this regard.
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